Yahoo Finance Resin Shortages Resonate Throughout the Real Estate Market
Resins are yet another material on a growing list of short supplies for construction. But what are they, and how are they used in building project completion?
Resins are yet another material on a growing list of short supplies for construction. But what are they, and how are they used in building project completion?
Recent CPI figures have revealed your salary isn't worth as much as last year. Find out how much of a rise you need to keep pace with inflation.
Luxembourg – 25 April 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, ISIN: LU0075646355, the Company) announced today results of Subsea7 Group (the Group, Subsea7) for the first quarter which ended 31 March 2024. First quarter highlights Adjusted EBITDA of $162 million, up 52% on the prior year period, equating to a margin of 12%Backlog remains robust at $10.4 billion, of which $4.8 billion to be executed in the remainder of 2024High tendering activity supports management’s confidence in the
ICG Enterprise Trust plc (the “Company”) 25 April 2024 Transaction in Own Shares The Company announces that on 24 April 2024 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1214 pence per share. Further details are set out below: Number of shares held as treasury shares following this purchase: 6,303,133.Total shares in issue excluding treasury shares following this purchase: 66,609,867. The Company has bought back these shares under the authority g
LONDON, April 25, 2024-- Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) today released its regular weekly Net Asset Value ("NAV") and performance returns on its website, https://pershingsquareholdings.com/performance/net-asset-value-and-returns/. The NAV and returns were computed as of the close of business on Tuesday, 23 April 2024.
LONDON and RALEIGH, N.C., April 25, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the first quarter ended March 31, 2024 on Thursday, May 9, 2024 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to discuss these financial results and provide a corporate update. To participate, please dial one of the following numbers and ask to join the Verona Pharma call: +1-83
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the ‘Company’) is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due course and are available on the Company’s website at www.galantas.com/investors. The Annual and Special Meeting of the Company is to be held at 11:00 a.m. (Toronto time) on 24th June 2024 at The Canadian Ve
The Q1 2024 results of AS Tallink Grupp will be introduced at an Investor Webinar held today at 12:00 (EEST). To participate, please join via the following link; we kindly ask participants to provide their questions latest by 11:00 by email to: investor@tallink.ee. Further details are available in a previously published announcement. In the first quarter (1 January – 31 March) of 2024 financial year, AS Tallink Grupp and its subsidiaries (the Group) carried 1 102 738 passengers, which is 5.0% mo
CAMBRIDGE, United Kingdom, April 25, 2024--Q1 Earnings Release (25 April 2024)
Oslo, 25 April 2024 - An Extraordinary General Meeting Adevinta ASA ("Adevinta" or the "Company") will be held on 16 May 2024 at 15:00 Oslo time. The Extraordinary General Meeting will be held as a digital meeting only, accessible online via Lumi AGM, with no physical attendance for shareholders. All shareholders will be able to participate in the meeting, vote and ask questions from smartphones, tablets or desktop devices. For further information regarding electronic participation, please refer
PARIS, April 25, 2024--Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical-stage biotechnology company focused on the development of glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, today announced the first results of its ACTISAVE phase 2/3 study in the treatment of acute ischemic stroke.
Press release25 April 2024, 08:00 Sdiptech AB (publ) publishes interim report for the first quarter (January-March) 2024The report is available on the company's website: www.sdiptech.se CONTINUED GROWTH WITH SOLID CASH FLOW FIRST QUARTER 2024 Net sales increased by 24% to SEK 1,335 million (1,076). In total for the Group, organic sales growth was 10%, excluding currency effects. EBITA, increased by 24% to SEK 255 million (206), corresponding to an EBITA margin of 19.1% (19.2)Adjusted EBITA incre
Boussard & Gavaudan Holding Limited (the “Company”) a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 Annual Report and Audited Financial Statements On 24 April 2024 the Company’s Board of Directors approved the Annual Report and Audited Financial Statements for the year ended 31 December 2023 (the “Annual Report”). The Annual Report is available on the Company’s website (w
Bank of Åland Plc Interim Report April 25, 2024 9.00 EET Interim Report for the period January - March 2024 “We started the year strongly and more than doubled our net operating profit to EUR 16.9 million (8.2). In addition, for the first time we surpassed EUR 10 billion in actively managed customer investments (8.9).” Peter Wiklöf, Managing Director and Chief Executive January−March 2024 compared to January - March 2023 Net operating profit more than doubled and amounted to EUR 16.9 M (8.2). Co
Nordecon AS and AS Tallinna Lennujaam signed a contract for the construction of platform area for E-class aircraft at Tallinn Airport. The total value of the contract is 7.5 million euros without VAT and the works will be completed in autumn of 2025. Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Ukraine and S
HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“VAALCO” or the “Company”) today announced the timing of its first quarter 2024 earnings release and conference call. The Company will issue its first quarter 2024 earnings release on Tuesday, May 7, 2024 after the close of trading on the New York Stock Exchange and host a conference call to discuss its financial and operational results on Wednesday morning, May 8, 2024 at 10:00 a.m. Central Time (11:00 a.m. E
Boussard & Gavaudan Holding Limited (the “Company”) a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 Annual Report and Audited Financial Statements On 24 April 2024 the Company’s Board of Directors approved the Annual Report and Audited Financial Statements for the year ended 31 December 2023 (the “Annual Report”). The Annual Report is available on the Company’s website (w
Boussard & Gavaudan Holding Limited (the “Company”) a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 Annual Report and Audited Financial Statements The Company has submitted its Annual Report and Audited Financial Statements for the year ended 31 December 2023 (the “Annual Report”) to the National Storage Mechanism and it will shortly be available for inspection at https:/
Quarterly information report as at the end of March 2024 Solid sales growth in the first quarter (+17% at constant exchange rates and +13% at current exchange rates) Paris, 25 April 2024 The group’s consolidated revenue amounted to €3,805 million in the first quarter of 2024, up 17% at constant exchange rates and 13% at current exchange rates, with a solid activity in all geographical areas. Axel Dumas, Executive Chairman of Hermès, said: “The solid sales growth in the first quarter 2024 reflect
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloserIrish Residential Properties Sub-Fund 1(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient
AMSTERDAM, April 25, 2024--Regulatory News: News release25 April 2024